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3D BIOMIMETIC PLATFORM
CROSS-REFERENCE TO RELATED PATENT
APPLICATION
This patent application claims the benefit of and priority
to U.S. Provisional Patent Application No. 61/839,409, titled
"31) BIOMIMETIC PLATFORM", filed on Jun. 26, 2013,
the contents of which are hereby incorporated by reference
in their entirety.
STATEMENT REGARDING FEDERALLY
SPONSORED RESEARCH OR DEVELOPMENT
The invention described herein was made by an employee
of the United States Government and may be manufactured
and used by or for the Government of the United States of
America for governmental purposes without the payment of
any royalties thereon or therefore.
BACKGROUND OF THE INVENTION
The inability to accurately determine the deleterious
effects on the human body after exposure to relevant space
conditions is a significant problem in the field of human
space flight and exploration. It is often not possible to
acquire this data in the actual environment, and conclusions
may therefore be drawn and data extrapolated on the health
effects anticipated. This method is not reliable because the
models used to generate data do not represent in vivo
conditions and the effects of individual stressors typically
tested neglect the influence of synergistic effects. The effects
of the environment in space have also been utilized to
develop treatments such as a vaccine for salmonella. How-
ever, simulating the space environment on the ground has
proven to be a significant challenge. One particular chal-
lenge has been with reliably correlating ground based data
with data obtained on the International Space Station (ISS).
BRIEF SUMMARY OF THE INVENTION
One aspect of the present invention is a ground-based
platform that more closely mimics the space environment. A
ground-based platform is any platform that is operated in
any combination of one or more of the following locations:
on and/or in the solid ground of the Earth, on and/or in any
body of water on the Earth, and/or within the lower atmo-
sphere of the Earth. In some embodiments the ground-based
platform is operated within one or more of the following: on
and/or in the solid ground, within the planetary boundary
layer, and/or within the troposphere. In embodiments the
ground-based platform is operated on and/or in the solid
ground and/or within the planetary boundary layer.
The present invention provides a way to simulate the
space environment on the ground as closely as possible to
evaluate the impact combined exposure to low-dose chronic
gamma radiation and simulated microgravity has on the
gene expression of human mesenchymal stem cells
(hMCSs), and to determine if there is a synergistic relation-
ship between the two stressors. The ground based 3D in vitro
platform incorporates synergistic effects from radiation and
microgravity and facilitates understanding the mechanistic
effects associated with these stressors. A predictive model
can be utilized to assess the risks associated with long term
space exploration and to allow for the testing of various
biological countermeasures. Furthermore, a reliable 3D in
vitro platform also allows for individualized screening of
2
astronauts for their radiation adaptability or susceptibility
through the use of their own cells.
The combined effects of the two stressors (simulated
microgravity and exposure to radiation) can also be utilized
5 to study diseases and develop treatments for diseases and
other health-related conditions. Specifically, a 3D Biomi-
metic test apparatus or platform according to the present
invention can be utilized for drug development by correlat-
ing ground-based research with research done on a spaced-
lo based platform such as the International Space Station (ISS).
For example, when stressed by a spaced-based environment
or a simulated space environment according to the present
invention (combined radiation and simulated microgravity),
15 bacteria may exhibit an expression of different genes and
protective proteins, which is the way that the bacterium
protects itself. The protective mechanism of the bacterium
becomes more evident, and this information can be utilized
to modify the bacterium to create a vaccination or other
20 treatment. A space-based environment or simulated space
environment speeds up the vaccination creation process
because the bacteria are stressed in a way that it is not
stressed on the Earth's surface. The present invention
thereby permits more rapid development of vaccines and
25 other treatments utilizing a ground-based platform having
significantly reduced cost relative to space-based
approaches. Various treatments for diseases, including dis-
eases caused by bacterium and/or viruses, may be developed
via the present invention including vaccines, antibiotic
3o drugs, antivirulent drugs and other antibacterial/antivirus
medications. In some embodiments the disease is caused by
at least one bacterium. In one embodiment the treatment is
a vaccine.
Exposure to chronic low-dose gamma radiation in simu-
35 lated microgravity is believed to result in synergistic effects.
The combined stressors are believed to work in synergy with
each other to intensify the effect of each individual stressor.
Accordingly, one aspect of the present invention involves
exposing a 3D scaffold comprising one or more of layers of
40 electroactive fibers to radiation while the 3D scaffold is
simultaneously subjected to simulated microgravity. The
present invention may utilize gamma radiation at very low
dose rates to provide chronic exposure to radiation. Micro-
gravity may be simulated utilizing a known rotating wall
45 vessel bioreactor to provide for ground based microgravity
experiments. The simulated microgravity bioreactor may be
positioned in a radiation field to obtain data on the combined
effects of radiation and microgravity. Focused microarrays
may be utilized to determine the influence on differentiation
5o and to examine changes such as oxidative stress effects,
DNA damage signaling, apoptosis and heat shock protein
response. These studies can be used to isolate the mecha-
nisms associated with each individual stressor and the
influence of combining the stressors in a more appropriate
55 space simulated environment.
In vitro studies preferably include the relevant biological
environment pertaining to the cells/tissues being studied in
vivo. A novel biomimetic 3D scaffold capable of delivering
biochemical, mechanical, electrical, architectural and topo-
60 graphical cues during culture which more closely mimic the
native environment is described in United States Patent
Application Publication No. 2011/0142806. This biomi-
metic 3D scaffold may be compared to conventional 3D
microcarrier beads currently used for the evaluation of cells
65 in simulated microgravity. This comparison may be utilized
to provide an understanding of the role morphology plays
when exposed to external stressors.
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One aspect of the present invention involves determining
the effect on gene expression for human mesenchymal stem
cells cultured in simulated microgravity using a biomimetic
3D scaffold.
A second aspect of the present invention involves deter-
mining the effect on gene expressing for human mesenchy-
mal stem cells cultured in a chronic low-dose gamma
radiation environment using a biomimetic 3D scaffold.
A third aspect of the present invention involves determin-
ing the effect on gene expression for human mesenchymal
stem cells cultured in a combined simulated microgravity
and chronic low-dose gamma radiation environment using a
biomimetic 3D scaffold.
A fourth aspect of the present invention involves deter-
mining the effect on human mesenchymal stem cells cultures
as in the third aspect with a "return to earth" stressor by
allowing the cell cultures to re-adapt prior to analyzing the
gene expression.
Embodiments of the invention include an assembly for
identifying the combined effects of microgravity and radia-
tion, wherein the assembly includes a bioreactor capable of
simulating reduced gravity in a test space of the bioreactor,
and a radiation source configured to provide radiation
whereby cells and/or bacteria and/or viruses disposed in the
test space are exposed to radiation. In some embodiments,
the assembly is a ground-based assembly/platform.
Some embodiments of the invention are a test assembly
for testing the combined effects of microgravity and radia-
tion. The test assembly includes at least a bioreactor capable
of simulating reduced gravity in a test space of the biore-
actor; a radiation source configured to provide radiation
whereby cells and/or bacteria and/or viruses disposed in the
test space are exposed to radiation.
Another embodiment of the invention is a ground-based
method of determining a response to combined environmen-
tal stressors, wherein the method provides a cell culture; and
exposes the cell culture to radiation from a radiation source
while the cell culture is simultaneously exposed to simulated
microgravity.
Still other embodiments of the invention are a method of
determining a response to combined environmental stress-
ors, wherein the method includes providing a cell culture;
exposing the cell culture to radiation from a radiation source
while the cell culture is simultaneously exposed to simulated
microgravity. In one embodiment this method is a ground-
based method that is performed on a ground-based assem-
bly/platform.
These and other features, advantages, and objects of the
present invention will be further understood and appreciated
by those skilled in the art by reference to the following
specification, claims, and appended drawings.
BRIEF DESCRIPTION OF THE SEVERAL
VIEWS OF THE DRAWINGS
FIG. 1 is a schematic view of a rotating bioreactor and
radiation source/environment according to one aspect of the
present invention;
FIG. 2 is a schematic view of a three dimensional (3D)
scaffold according to one aspect of the present invention;
FIG. 3 is a graph showing the pyroelectric profile of beta
phase PVDF;
FIG. 4A is an optical microscopy image of an electrospun
3D fiber scaffold;
FIG. 4B is an optical microscopy image illustrating live/
dead assay results for human mesenchymal (hMSC) for
IrMSCs cultured for seven days on the scaffold of FIG. 3A;
4
FIG. 5 shows gene expression after seven and fourteen
days in vitro for a 3D fiber scaffold;
FIG. 6A is an image of cytoskeleton protein expression
F-actin (green) and intermediate filament protein vimentin
5 (red) with the nuclei (blue) for IrMSCs after seven days in
culture on a 2D surface;
FIG. 6B shows an image of cytoskeleton protein expres-
sion F-actin (green) and intermediate filament protein
vimentin (red) with the nuclei (blue) for IrMSCs after seven
10 days in culture on a 3D fiber scaffold;
FIG. 7A is an image showing expression of gap junction
protein connexin-43 (green) and focal adhesion protein
vinculin (red) for IrMSCs after fourteen days in culture on a
2D surface;
15 FIG. 7B is an image showing expression of gap junction
protein connexin-43 (green) and focal adhesion protein
vinculin (red) for IrMSCs after fourteen days in culture on a
3D fiber scaffold;
FIG. 8 is a western blot gel image illustrating protein
20 expression after seven and fourteen days for IrMSCs cul-
tured on CP2 and PVDF fibers;
FIG. 9 is a graph showing the results of cells that were
seeded (I OK-30K cells/well) irradiated for 48 hours, and cell
count determined by trypan blue excursion;
25 FIG. 10 is a chart showing genes downregulated after 48
hour exposure to radiation; and
FIG. 11 is a chart showing genes upregulated after 48
hours exposure to radiation.
30 DETAILED DESCRIPTION OF THE
INVENTION
For purposes of description herein, the terms "upper,"
"lower," "right," "left," "rear," "front," "vertical," "horizon-
35 tal," and derivatives thereof shall relate to the invention as
oriented in FIG. 1. However, it is to be understood that the
invention may assume various alternative orientations and
step sequences, except where expressly specified to the
contrary. It is also to be understood that the specific devices
4o and processes illustrated in the attached drawings, and
described in the following specification, are simply exem-
plary embodiments of the inventive concepts defined in the
appended claims. Hence, specific dimensions and other
physical characteristics relating to the embodiments dis-
45 closed herein are not to be considered as limiting, unless the
claims expressly state otherwise.
Future human space missions will require crew to travel
beyond low earth orbit (LEO) for extended periods of time
exposing them to the harsh space environment which poses
5o both acute and chronic risks to crew health and safety that
have clinically relevant implications for their lifetime. Two
of the primary environmental stressors creating health chal-
lenges for crew are radiation and microgravity. Galactic
cosmic rays (GCR) are ubiquitous in space and generate a
55 mixed field of ionizing radiation that is difficult to shield
against. In low earth orbit, there is significant protection
from the Earth's magnetosphere; even so, the International
Space Station ("ISS") averages a chronic low-dose rate of
500 µGy/day with modest shielding measures in place.
60 Microgravity has been known to cause health issues for
astronauts long after their return to earth. Several studies
have been performed using a known simulated microgravity
bioreactor in order to understand the space environment
better and develop appropriate countermeasures. Correlating
65 the ground based results using the simulated microgravity
bioreactor to those obtained in space has proven to be a
challenge. Part of this challenge is due to the low level
US 9,557,322 B2
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radiation stressor that is chronically present during the space
studies yet absent when performed on the ground.
In vitro models are ideal for developing fundamental
knowledge of biological mechanisms and are relatively
inexpensive compared to in vivo studies. However, in order
to derive true meaning from the data, it may be necessary to
replicate the in vivo environment as closely as possible. As
discussed in more detail below, the present invention utilizes
a 3D biomimetic scaffold system that mimics in vivo con-
ditions.
One aspect of the present invention is a representative
space analog that permits in vitro experiments to determine
differences due to each individual stressor, microgravity and
radiation, and to examine the combination of the stressors to
establish if the effect is synergistic and the underlying
mechanisms associated with each stressor.
Some studies concerning the effects of simulated micro-
gravity on hMSCs have been conducted. Simulated micro-
gravity reportedly reduces the expression of collagen type I,
ALP and ERK activation, increases markers for adipocyte
differentiation and induces p38 activation in hMSCs. In one
study hMSCs were cultured for a period of seven days to
evaluate the osteoclastogenesis and osteoblastogenesis using
a known simulated microgravity bioreactor. The results
showed that the environment inhibited osteoblastogenesis
even with osteogenic induction and increased adipocyte
differentiation. The hMSCs differentiation profile and gene
expression following exposure to simulated microgravity (in
the absence of applied low dose radiation) may be examined
to determine the effect on various genes and pathways.
Some studies concerning low-dose radiation effects on
hMSCs have also been conducted. Cellular studies with
ionizing radiation have shown cytotoxic effects for high
doses (>2 Gy) and transcriptional effects at low doses (<2
Gy). 7in et al exposed hMSCs to very low doses: 0.01, 0.05,
0.2 and 1 Gy of gamma radiation and performed microarray
analysis at four different timepoints: 1, 4, 12, and 48 hours
post-irradiation. Results showed a non-linear pattern in
cellular activity with respect to dose. According to one
aspect of the present invention, experiments may be per-
formed at 3 different doses and 3 different time points.
Several genes associated with cellular stress response may
be analyzed to help determine if a non-linear pattern exists.
Genetic changes may be examined immediately post-irra-
diation to assess the effects of chronic radiation.
It is generally believed that microgravity enhances the
effect of radiation though synergistic effects that have not
been effectively established. Manti et al exposed peripheral
blood lymphocytes to X-rays at doses between 0-6 Gy then
cultured them in a rotating wall vessel microgravity biore-
actor to determine the synergistic effects. Another group
exposed human fibroblasts to y irradiation prior to the space
mission to determine synergistic effects. True synergy; how-
ever, requires exposure to radiation and microgravity simul-
taneously due to the sensitive nature of biological processes.
The present invention achieves synergy on the ground by
subjecting a rotating wall vessel (RCCS) bioreactor to
chronic low-dose gamma radiation simultaneously through-
out the experiment. Gene expression may be analyzed
immediately following exposure to the combined stressors
as well as at multiple time points post-irradiation to provide
the cells with a pseudo return to earth (gravity) environment
to include the adaptation effects that may be experienced by
the Crew. I expect to see an influence in both gene and
protein expression compared to the individual stressors of
microgravity and gamma radiation in addition to the return
to earth environment.
6
Cell culture has conventionally been performed in a dish
which offers a 2D environment that does not take in vivo
conditions into consideration since the body exists in three
dimensions. In the 1980's the concept of culturing cells on
5 synthetic scaffolds paved the way for a new research area in
scaffolds for tissue engineering and began a quest for the
ideal biomaterial and the development of biomimicking 3D
scaffolds. A great deal of attention was focused on the
development of biodegradable scaffolds that could be tai-
io lored such that their degradation properties would depend on
the cell culture time and the organ in which they were
targeting. Common materials include polyglycolic acid
(PGA), polyethylene glycol (PEG), polylactic -glycolic acid
(PLGA), polyurethane, polycaprolactone (PCL), chitosan,
15 collagen, hyaluronic acid, hydroxyapatite and elastin-like
polymer.
The goal in scaffold fabrication is to create an environ-
ment that mimics the native tissue in vivo for optimal in
vitro regeneration. Current trends have focused on the
20 development of biofunctional materials and scaffolds, i.e.
the ability to apply stimuli to the cells in vitro. The stimuli
can be one of several forms such as a change in pH or
temperature, delivery of growth factors, proteins or DNA
upon scaffold degradation, and immobilization of functional
25 groups on the surface to promote cell attachment or cell-
substrate interactions. Fabrication of scaffolds has advanced
rapidly over the past two decades resulting in a variety of
techniques to produce novel scaffolds for cell culture. There
are three popular forms of scaffold constructs that provide a
3o 3D environment, gels, microcarrier beads and macroporous
fibrous structures. Gels produced from collagen, fibrin,
gelatin, and alginate demonstrate favorable results compared
to conventional 2D systems when used to culture specific
cell types; however, they are not ideal for use in the
35 microgravity bioreactor. Microcarrier beads have been used
successfully in several studies to create an environment for
cell attachment in the microgravity bioreactor. Scaffolds
fabricated from fibers with diameters ranging from mano-
meters to micrometers have also been investigated exten-
40 sively as 3D constructs, however; few studies have
employed this particular design as their model in the micro-
gravity bioreactor. There are several techniques available
that produce 3D structures though obtaining the ideal com-
bination of feature size, controlled porosity and material
45 selection is still under investigation.
One promising processing technique that has the ability to
tailor all three areas is electrospinning. Electrospun scaffolds
have been fabricated from a multitude of biocompatible
polymers with size features ranging from micro to nanome-
50 ter. The fibers formed, particularly those with nanoscale
diameters, may represent much of the connective tissue
found in vivo. Aligned fibers have been investigated exten-
sively and shown to promote cell alignment and attachment
due to their high surface to volume ratio. Studies suggest
55 that a fibrous structure plays a fundamental role in the
modeling of the extracellular matrix and overall gene
expression. The porosity can be controlled enough to allow
for ample exchange of nutrients, waste and oxygen to the
cells, thus electrospinning has been chosen as the method to
60 produce scaffolds for analysis in this particular study.
Recent studies have reported significant differences in the
end points observed when comparing 2D and 3D in vitro
models exposed to ionizing radiation. In a study performed
by Zschenker et. al., two human cancer cell lines, A549 lung
65 cancer cells and UT-SCC15 head and neck squamous cell
carcinoma, were seeded on 3D spheroids and compared to
the conventional 2D culture dish after exposure to various
US 9,557,322 B2
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X-ray doses ranging from 0-6 Gy at 200 W. The researchers
found little difference in DNA repair when comparing the
2D and 3D environments but noted significant changes in
biological functions such as tissue development, cell adhe-
sion and defense response between them. Their results
emphasize the importance of studying cell culture in a 3D
environment and the profound impact the in vitro environ-
ment has on gene expression. The researchers also noted the
importance of the environment on cell-cell communication
since it is strongly influenced by cell -extracellular matrix
contacts which were significantly affected when comparing
the 2D and 3D in vitro environments. It is important to
understand not only the architectural but the topographical,
mechanical, electrical and biochemical influences on the
cell-extracellular matrix relationship. As evidenced in the
work reported by Cordes and Beinke, the cell culture matrix
played a central role in the radiation response for p53
wild-type A5A9 lung cancer cells when cultured on
fibronectin, polystyrene and bovine serum albumin. They
reported a higher survival rate for cells cultured on fibronec-
tin compared to the other cell culture models. This is an
important finding that needs to be factored in during in vitro
observations since multiple models are typically employed
to study radiation effects. A 3D fiber scaffold system accord-
ing to the present invention can be compared to 3D micro-
carrier beads which will allow a preliminary comparison
regarding this aspect. The difference between 2D and 3D
cell culture environments and their influence on the extra-
cellular matrix as well as cell-cell communication may also
be examined.
The present application is related to United States Patent
Application Publication No. 2009/0108503 filed on Jun. 2,
2008, United States Patent Application Publication No.
2010/0201384 filed on Feb. 10, 2010, United States Patent
Application Publication No. 2010/0211151 filed on Feb. 3,
2010, and United States Patent Application Publication No.
2011/0142806 filed on Dec. 15, 2010, the entire contents of
each of which is incorporated herein by reference. These
patent publications describe a modified electrospinning pro-
cess that controls fiber deposition to produce aligned fibers
and mats. Using this technique, aligned electroactive fibers
and mats have been fabricated from polyvinylidene fluoride
(PVDF) polymer. The pyroelectric properties of the fibers
have contributed to the differentiation of human mesenchy-
mal stem cells in preliminary laboratory studies.
With reference to FIG. 1, a test set-up 25 according to one
aspect of the present invention includes a bioreactor 10 that
simulates zero gravity and/or microgravity. In the illustrated
example, a known rotating wall bioreactor 10 having one or
more rotating test spaces 16 is utilized. As used herein, the
term "bioreactor" generally means any device or combina-
tion of devices that are capable of simulating zero gravity
and/or microgravity. Cell cultures 6 are disposed in the
rotating test spaces 16. Cell cultures 6 may comprise virtu-
ally any living matter and/or viruses. For example, cell
cultures 6 may comprise human, plant, or animal cells (e.g.
stem cells), bacteria, and/or viruses. In use, the rotating test
spaces 16 rotate to thereby expose the cell cultures 6 to a
simulated microgravity environment. The bioreactor 10 may
comprise a known rotating wall vessel bioreactor including
a control unit 8 that provides for control and monitoring of
the bioreactor 10 during testing. As discussed in more detail
below, the cell cultures 6 may comprise three dimensional
fibrous scaffolds that mimic an in vivo environment,
whereby cells are cultured on the scaffold. Alternatively, cell
cultures 6 may comprise 2D cell cultures.
8
Referring again to FIG. 1, the bioreactor 10 may be
positioned inside an incubator 12 having an interior space 13
providing a controlled temperature as may be required for a
particular application. The incubator 12 may be positioned
5 inside a test facility 18 that includes a radiation source 14
that is in line with incubator 12 such that the cell cultures 6
in rotating test spaces 16 are exposed to gamma radiation
"R" from radiation source 14. Radiation source 14 may
comprise a known low-dose gamma radiation source pro-
io viding about 500 µGy/day. Thus, the test set-up 25 permits
the cell cultures 6 to be simultaneously exposed to simulated
microgravity and low dose gamma radiation for a predefined
period of time. The cell cultures 6 may be simultaneously
exposed to low dose gamma radiation and simulated micro-
15 gravity utilizing test set-up 25 for periods of time ranging
from, for example, 24 or 48 hours to 7 or 14 days. The cell
cultures 6 may be simultaneously exposed to low dose
gamma radiation and simulated microgravity for longer
periods of time (e.g. months or years) if required for a
20 particular test or research project. According to other aspects
of the present invention, cell cultures 6 may be exposed to
radiation and microgravity in a sequential or alternating
manner. For example bioreactor 10 may be activated for a
first period of time while the radiation source 14 is deacti-
25 vated or moved away from bioreactor 10 such that cell
culture 6 is only subjected to microgravity during the first
time period. After the first period of time has passed, the
radiation source may then be activated or moved into the
vicinity of bioreactor 10 for a second period of time while
30 the bioreactor is deactivated (or while the cell cultures may
be removed from bioreactor 10). The first and second time
periods may be equal, or they may be significantly different.
Radiation source 14 may also be configured to provide
higher dose gamma radiation and/or other radiation. For
35 example, radiation source 14 may be configured to provide
ionizing radiation that is substantially similar to radiation
that exists outside the earth's atmosphere.
With further reference to FIG. 2, a three dimensional
scaffold 1 according to one aspect of the present invention
40 may comprise a plurality of layers 2, wherein each layer 2
comprises a plurality of fibers 4. The fibers 4 may be
oriented to provide an alternating 0°/90° layup. Although
four layers 2 are shown in FIG. 2, it will be understood that
the 3D scaffold 1 may comprise significantly more layers
45 (e.g. 30-100 or more layers). The fibers 4 may comprise
electrospun polymer fibers as disclosed in U.S. Patent Pub-
lication No. 2009/0108503. For example, the fibers 4 may
comprise electrospun polyvinylidenefluoride (PVDF) poly-
mer. The 3D scaffold 1 may comprise an electroactive
50 scaffold as disclosed in U.S. Patent Publication No. 2011/
0142806. However, it will be understood that the present
invention is not limited to a particular material composition
with respect to the fibers 4, and various polymer materials or
other materials may be utilized in 3D scaffold 1 as may be
55 appropriate for a particular application. Still further, it will
be understood that the 3D scaffold 1 could comprise a
variety of fibrous or non-fibrous macroporous structures. In
general, the 3D scaffold 1 has a sufficient thickness "T" to
mimic a native environment.
60 In a preferred embodiment, the cell cultures 6 include a
3D scaffold 1 and cells such as human mesenchymal stem
cells or other cells and/or viruses. During testing, the 3D
scaffold 1 is disposed in the rotating test spaces 16 such that
the 3D scaffold 1 rotates with the test spaces 16. As
65 discussed in more detail below, the effects of the combined
microgravity and radiation exposure can be evaluated to
determine the response of the cells in the cell cultures 6.
US 9,557,322 B2
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A 3D fiber scaffold according to one aspect of the present
invention mimics the in vivo environment more closely by
delivering the requisite biochemical, mechanical, electrical
and topographical cues during culture and will provide more
realistic data using an in vitro model to determine the 5
intracellular signaling, cell-cell communication, and cyto-
skeleton formation and motility. The 3D fiber scaffold is
fabricated from a ferroelectric polymer, poly vinylidene
fluoride (PVDF) that generates a slight current during cul-
ture at 37° C. due to its intrinsic pyroelectricity. The pyro- io
electric profile for the beta phase (polar) of this material is
illustrated in FIG. 3. Electrical stimulation has been impli-
cated in three key areas on the cellular level including the
physical environment, growth factors and signal transduc-
tion cascade. However, incorporating electrical stimuli dur- 15
ing cell culture has been virtually overlooked until recently.
A 3D scaffold according to aspects of the present invention
may include aligned fibers which represent much of the
connective tissue found in vivo and it is porous enough to
allow for ample exchange of oxygen, nutrients and waste 20
during culture.
A 3D in vitro model according to another aspect of the
present invention may comprise multiple layers, of aligned
electroactive fibers. An external electric field can be applied
to the fibers of each layer in vitro. In vitro studies utilizing 25
an applied voltage of 10 mV have shown a significant
influence on the differentiation of human mesenchymal stem
cells. This is relevant because much of the in vivo tissue and
cells are electrically active. The ability to vary the voltage
and apply it to the individual layers allows the researcher to 30
tailor the electrical influence based on the tissue/cell of
interest. This model can be used to perform synergistic
experiments on human cell lines and aids in the development
and assessment of biological countermeasures, risk predic-
tion models and individualized astronaut screening. 35
Human mesenchymal stem cells (hMSCs) are an ideal cell
line for use in a study according to the present invention due
to their multipotent capability to differentiate into various
lineages in vitro and for their therapeutic potential. Further-
more, IrMSCs have been explored extensively for the assess- 40
ment of osteogenesis in vitro. Since they have been studied
in vitro in both simulated microgravity and in space there is
previously reported data with which to compare the results
of the present invention. IrMSCs may be isolated from bone
marrow, seeded on tissue culture polystyrene plates and 45
cultured with antibiotics using Dulbeccos Modified Eagle's
Medium and fetal calf serum for 7 days at 37° C. in 5% CO2
environment. To date there is little data on the influence of
the in vitro environment during exposure to ionizing radia-
tion. The in vitro environment is a critical component that 50
will influence intracellular signaling, cell-cell communica-
tion, and cytoskeleton formation and must be examined
critically for data generated to be relevant.
Several research groups have employed whole genome
analysis to examine effects of disease or stressors in their 55
studies. This is an excellent technique that comes with a host
of challenges. There are more than 33,000 genes to be
analyzed creating a much larger pool of data and requiring
significantly more time to analyze and interpret the data.
Focused microarrays arose as a simplified high-throughput 60
platform that allows the researcher to focus in on particular
pathways or diseases without needing extensive microarray
systems and software to generate and analyze the data. The
focused microarrays can be performed using a real-time
PCR machine and the data can be analyzed and interpreted 65
in hours or days as opposed to months. Wurmbach et al.
performed a study to analyze focused microarrays and
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reported greater sensitivity and accuracy with excellent
repeatability. Focused microarrays (available from SA Bio-
science) may be utilized in studies according to the present
invention. These microarrays include 84 genes and multiple
housekeeping genes spanning various pathways depending
on the area of interest. Utilization of focused microarrays
from a commercial supplier allows the research to be
repeated much more readily in an independent laboratory for
verification.
A first object of the present invention is to determine the
effect on gene expression for human mesenchymal stem
cells cultured in simulated microgravity using a biomimetic
3D scaffold. Studies/processes according to the present
invention may utilize 3D microcarrier beads as the standard
control and a 3D fiber scaffold to culture IrMSCs in a
microgravity bioreactor to determine the effect of simulated
microgravity. Gene expression changes may be evaluating
using gPCR focused microarrays after multiple time points:
72 hours, 7 days and 14 days. RNA may be extracted
immediately using a commercially available RNEASY
minikit (Qiagen) following each time point to detect changes
associated with the microgravity stressor. The gPCR focused
microarrays may be utilized to examine pathways associated
with cell stress and disease, DNA damage, and the cell cycle.
Since IrMSCs are known to differentiate into various lin-
eages, stem cell differentiation focused microarrays may
also be run to assess the impact of this environment on their
differentiation. The gene expression changes for IrMSCs
cultured on 3D microcarrier beads and fiber scaffold under
static conditions at the same time points may be utilized as
a reference. IrMSCs cultured in tissue culture polystyrene
may be included in the experiments/processes to provide an
additional baseline control. The resulting data may be sta-
tistically analyzed using analysis of variance (ANOVA).
To observe the effects of radiation on the cytoskeleton,
samples may be fixed in 4% PEA, permeabilized with 0.25%
Triton-X 100 and stained for immunofluorescence imaging
of cytoskeleton proteins F-actin and intermediate filament
protein vimentin with the nuclei counterstained using DAPI.
Cell-cell communication may be examined by immunos-
taining for connexin-43. Confocal laser scanning micros-
copy may be used to observe cell morphology, cytoskeleton
and cell-cell communication proteins. Protein expression
may be determined for each sample of interest using Western
Blot. Cells may be lysed using RIPA buffer containing
protease inhibitor at the pertinent timepoints determined
post-irradiation. Total protein concentration may be quanti-
fied using a bicinchoninic acid (BCA) kit. Protein samples
(10 µg) containing 2x Laemmli buffer may be loaded in
polyacrylimide ready gels and electrophoresis run using
SDS-PAGE buffer. The protein may be transferred from the
gel to a nitrocellulose membrane using an electrophoresis
chamber in a cold room. The nitrocellulose membrane may
be placed in a blocking mixture of 5% nonfat milk in TBS
containing 0.1 % Tween for a minimum of 1 hour prior to the
addition of the primary antibodies. Primary antibodies may
be incubated overnight in the cold room. The samples may
be washed 3x then incubated with the secondary antibodies
for a minimum of one hour. After the samples have been
washed 3x, the antibody detection solution may be added to
the membrane and incubated for 5 minutes. The membrane
may be exposed to the camera without a filter for two time
periods, 5 minutes and 10 minutes using a Kodak® Gel
Logic 200. The protein of interest may be analyzed using the
Kodak® Imaging software by normalizing the protein band
to the housekeeping protein GAPDH.
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A second objective of the present invention is to deter-
mine the effect on gene expression for human mesenchymal
stem cells cultured in a chronic low-dose gamma radiation
environment using a biomimetic 3D scaffold. Studies/pro-
cesses according to the present invention may use 3D 5
microcarrier beads as the standard control and a 3D fiber
scaffold to culture IrMSCs in tissue culture plates, and
determine the effect of low-dose Co-60 gamma radiation at
3 different total doses: 0.25 Gy, 0.5 Gy, and 1 Gy. These dose
levels are consistent with permissible exposure limits estab- io
lished for the astronaut core and those expected on missions.
Gene expression changes may be evaluated using gPCR
focused microarrays after multiple time points: 72 hours, 7
days and 14 days of chronic radiation exposure. RNA may
be extracted immediately following each time point to detect 15
changes associated with chronic radiation exposure. As a
reference, the gene expression changes for IrMSCs cultured
on 3D microcarrier beads and 3D fiber scaffold in the
absence of radiation at the same time points may be deter-
mined. IrMSCs cultured in tissue culture polystyrene may be 20
included in the experiments to provide an additional baseline
control. Data may be statistically analyzed using analysis of
variance (ANOVA). The data generated will also facilitate
the development of a low-dose profile dose response curve.
Proteins of interest may be examined by immunostaining, 25
visualized with confocal microscopy imaging and confirmed
by western blot. The protocol may be similar to that
described above in connection with the first objective.
The chemical and topographical features of the scaffold
play a critical role in the formation of the extracellular 30
matrix and contribute to cell-cell communication. Altera-
tions in the in vitro scaffold environment due to radiation
may play a role in differences observed in the cytoskeleton
as well as the long term effects resulting from cell signaling
adaptation. The influence of the different 3D cell culture 35
models may be examined by exposing the cell culture
scaffold alone to radiation and examining the surface effects
to determine if there is a significant alteration in the cell
culture environment that may be contributing to the results.
To assess the contribution of the in vitro environment, cell 40
culture models including polystyrene (21)), 3D microcarrier
beads and 3D fiber scaffolds may be exposed to the same
dose and LET radiation used in connection with the first
objective. Surface properties of each model will be analyzed
using Fourier Transform Infrared Spectroscopy (FTIR) and 45
imaged using scanning electron microscopy (SEM) to deter-
mine changes in the surface features and chemical compo-
sition post-irradiation.
A third objective of the present invention is to determine
the effect on gene expression for human mesenchymal stem 50
cells cultured in a combined simulated microgravity and
chronic low-dose gamma radiation environment using a
biomimetic 3D scaffold. 3D microcarrier beads may be used
as the standard and a 3D fiber scaffold to culture hMSCs, and
determine the effect of simulated microgravity combined 55
with chronic low-dose Co-60 gamma radiation at 3 different
total doses similar to those of the second objective: 0.25 Gy,
0.5 Cry and 1 Gy. The experimental set-up described in
connection with the third objective has been evaluated using
dosimeters in a low-dose Co-60 gamma radiation facility. 60
The microgravity bioreactor may be housed in an incubator
fitted with a glass door positioned at a designated point away
from the source to achieve the total dose/dose rate desired.
The incubator may remain in the radiation field throughout
the entire experiment providing a chronic low-dose radiation 65
exposure. Gene expression changes may be evaluated using
gPCR focused microarrays after multiple time points of
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chronic radiation exposure similar to the first objective: 72
hours, 7 days and 14 days. RNA may be extracted imme-
diately following each time point to detect changes associ-
ated with the combined stressors. As a reference, the gene
expression changes for IrMSCs cultured on 3D microcarrier
beads and 3D fiber scaffold under static conditions with and
without radiation at the same time points. IrMSCs cultured
in tissue culture polystyrene may be included in all experi-
ments to provide an additional baseline control. All data may
be statistically analyzed using analysis of variance
(ANOVA).
Proteins of interest may be examined by immunostaining,
visualized with confocal microscopy imaging and confirmed
by western blot. The protocol to be performed may be
similar to that described in connection with the first objec-
tive.
A fourth objective is to determine the effect on human
mesenchymal stem cells cultured as in the third objective
with a ` return to earth' stressor by allowing the cell cultures
to re-adapt prior to analyzing the gene expression. In order
to protect humans from the deleterious effects of space it is
necessary to consider post-flight changes that they may
experience upon return to earth. Several studies have inves-
tigated the effect of radiation or microgravity after the cells
have had a period of time to repair or adapt. The previous
aims represent more closely the environment experienced by
humans during a space mission but do not account for the
return to earth and cellular changes associated with that
stressor. For these studies, experiments will be performed as
in the third objective; however, following exposure to
chronic radiation, cell cultures are returned to a gravity
environment without radiation exposure and gene expres-
sion is analyzed after 24 and 48 hours post-irradiation. This
provides information on the adaptation of the cell cultures to
the space simulated environment.
3D fiber scaffolds mimic the in vivo environment more
closely than conventional cell culture models by delivering
the requisite biochemical, mechanical, electrical and topo-
graphical cues during culture and provide more realistic data
using an in vitro model to determine the intracellular sig-
naling, cell-cell communication, and cytoskeleton formation
and motility. 3D fiber scaffolds with semi-controlled poros-
ity consisting of highly aligned fibers (FIG. 4A) have been
developed for in vitro tissue engineering applications. Live/
dead assay (FIG. 413) confirmed human mesenchymal stem
cells (hMSCs) attach and proliferate on the aligned fibers.
Preliminary studies comparing the influence of a 2D envi-
ronment to a 3D fiber scaffold show a significant influence
on gene and protein expression for human mesenchymal
stem cells (hMSCs) after 7 and 14 days in culture. Exami-
nation of 28 genes representing the mesoderm, endoderm
and ectoderm layers resulted in upregulation of 17 genes on
the 2D surfaces (not shown), indicative of a heterogenous
population, while the 3D scaffold upregulated 10 genes, just
over half as many (FIG. 5). This indicates significant 3D
fiber scaffold differences in cell-cell signaling and extracel-
lular matrix formation and suggests the fiber scaffold is
playing a role in cytoskeleton organization and intermolecu-
lar signaling. Immunofluorescence imaging of F-actin and
intermediate filament protein vimentin depicting the cyto-
skeleton are illustrated in FIGS. 6A and 6B. The cells show
distinctly different phenotypes when cultured on the differ-
ent substrates. The nuclei are elongated along the fibers and
much more rounded on the flat, 2D surface (FIG. 6A).
Protein F-actin is shown expanding in web-like morphology
across the fibers (FIG. 613) and aligning unidirectionally on
the 2D surface. Immunofluorescence staining of gap junc-
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tion protein connexin-43 illustrated in FIG. 713, shows good
cell-cell communication occurring across the fibers in the
3D fiber scaffold and elongation of the nuclei attached to
each fiber compared to a 2D polystyrene surface as illus-
trated in FIG. 7A. The expression of focal adhesion protein, 5
vinculin, shown in FIG. 7 (red), indicates the sites of
attachment to the extracellular matrix.
Due to the intrinsic electrical properties associated with
the 3D fiber scaffold, protein expression specific to electri-
cally active cells was examined. hMSCs were cultured on io
various 2D surfaces including CP2 (polyimide) film, PVDF
film, coverslip (control) and coverslip conditioned with
retinoic acid (positive control), 3D fiber surfaces fabricated
from CP2 and PVDF. Microtubule associated protein
(MAP2) was probed using Western blot. Gel images (not 15
shown) indicate that the protein was upregulated for all
surfaces after 7 days in culture with fibers continuing to
upregulate MAP2 after 14 days in culture and the 2D
surfaces downregulating the protein. The 3D fiber scaffolds
expressed MAP2 2.5 fold more than the positive control 20
conditioned with retinoic acid after 14 days in culture. These
results demonstrate the significant influence the in vitro
model has on gene and protein expression and how the
various materials and architecture contribute to intracellular
signaling, cell-cell communication and cytoskeleton orga- 25
nization.
hMSCs are considered radioresistant, potentially in part
due to a resistance to apoptosis and DNA repair responses
when exposed acutely to gamma radiation. In contrast, the
effect of chronic, low dose radiation on hMSC has not been 30
thoroughly studied. Preliminary data generated in tissue
culture polystyrene (TCPS) suggest chronic exposure (48 hr)
to y-radiation (0.1541 Gy/hr) under static conditions
decreased hMSC proliferation (FIG. 9). There was no
increase in cell death observed by trypan blue exclusion 35
(data not shown). Focused microarrays were used to analyze
genes and pathways associated with cellular stress. A com-
parison between cells cultured on TCPS with and without
radiation after 48 hours is shown in FIGS. 10 and 11.
Downregulation of 15 genes was observed while six genes 40
were upregulated including superoxide dismutase (SOD2)
which has been reported by several researchers as a key gene
expressed during radiation exposure. RAD23A, a protein
involved in nucleotide excision repair, was upregulated
more than 3 fold although ERCCI which is also involved in 45
nucleotide excision repair was downregulated. Overall, the
genetic changes that occurred during this pilot study pro-
vided important information that needs further examination
to understand what is occurring at the genetic level during
chronic exposure. The downregulation of tumor suppressor 50
protein p53 and upregulation of MDM2 suggest a degrada-
tion in the p53 protein associated with MDM2 binding.
PRDXI and PRDX2 are linked to antioxidants that play
protective roles in cells. Both genes were downregulated
having negative implications since a recent study reported 55
that mice lacking PRDXI produce more cellular reactive
oxygen species (ROS) which plays a role in cancer devel-
opment or progression. It will be important in future studies
to probe deeper into ROS production and the role of p53
during chronic radiation exposure. This observation set the 60
precedent for observable differences between non-irradiated
and chronic, low dose y-irradiated hMSC.
A first study according to the present invention was
performed to verify the 3D scaffold 1 (FIG. 2) was com-
patible with the simulated microgravity bioreactor 10 (FIG. 65
1). Human mesenchymal stem cells were seeded at 200,000
cells/mL onto the 3D scaffold 1 and allowed to incubate for
14
a minimum of thirty minutes prior to loading onto the
bioreactor 10. A Synthecon RCCS-4CS bioreactor with 4
mL vessels was used to simulate microgravity. The pre-
seeded scaffolds 1 were placed in the bioreactor 10 along
with fresh media and rotated at 22 RPM in a 5% CO2, 37°
C. humidified incubator for 48 hours. After 48 hours, the
samples were removed and RNA extracted using RNEASY
minikit. Cell stress and toxicity focused microarrays were
used to analyze the gene expression. The scaffold 1 in the
microgravity bioreactor 10 was compared to the same scaf-
fold under static conditions. Preliminary results indicated
upregulation of heat shock proteins HSPA2 and HSPEI
which have been reported by several researchers in previous
studies and has been hypothesized to protect against apop-
tosis. Two additional genes that showed significant change
were Annexin A5 and insulin-like growth factor binding
protein-6. Only one gene showed a significant downregula-
tion when comparing the two environments, XRCCI, which
is involved in DNA repair. This is not surprising since one
would not expect to see considerable DNA damage in the
absence of radiation. The first study verified that the cells
can be cultured on the scaffold 1 successfully using the
microgravity bioreactor 10 and that there are notable
changes between the static and microgravity conditions.
A second study according to the present invention was
performed to validate the experimental set-up 25 (FIG. 1).
hMSCs were seeded on the 3D scaffold 1 and allowed to
incubate for a minimum of 30 minutes. The pre-seeded
scaffolds 1 were placed in the bioreactor 10 along with fresh
media and rotated at 22 RPM in a 5% CO2, 37° C.
humidified incubator 12 for 48 hours. The incubator 12 was
specially designed with a plexiglass door to accommodate
radiation experiments. Dosimetry for the set-up involved
analyzing alanine pellets in both the microgravity bioreactor
10 and static tissue culture dishes. The microgravity biore-
actor 10 set-up was positioned at a distance from the Co-60
radiation source 14 to deliver a total of 7.4 Gy of chronic
gamma radiation over a period of 48 hours. After 48 hours,
the samples were removed and RNA extracted using
RNEASY minikit to verify the set-up.
Radiation and microgravity are extreme stressors that
humans will be chronically exposed to during future long
duration space missions. Determining the impact of chronic
low-dose radiation exposure coupled with simulated micro-
gravity will assist in understanding the underlying mecha-
nisms associated with each stressor as well as determine the
extent to which combined effects may exist. Uncovering the
mechanisms will help lead to more effective countermea-
sures to protect crew health while studying these effects in
a more realistic 3D environment and provide a clearer
indication of the changes expected in vivo.
The overall objectives of the present invention/study are
to determine 1) if there are synergistic effects resulting from
combined radiation and microgravity stressors, 2) an under-
standing of the influence of the in vitro cell culture envi-
ronment by examining two different 3D scaffolds and com-
paring them to conventional 2D tissue culture environment
and 3) obtain an understanding of the effect of return to earth
and changes associated with that stressor. An experiment on
the ISS that closely mimics the ground based set-up of the
present invention will help to determine if the simulated
microgravity bioreactor along with the biomimetic 3D scaf-
fold provide a suitable analog for future ground-based
microgravity studies. Another objective of the present inven-
tion is to establish baseline studies to not only to compare to
ISS, but to other irradiation facilities that can do low level
chronic exposure.
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The preceding description of the disclosed embodiments
is provided to enable any person skilled in the art to make
or use the present invention. Various modifications to these
embodiments will be readily apparent to those skilled in the
art, and the generic principles defined herein may be applied
to other embodiments without departing from the spirit or
scope of the invention. Thus, the present invention is not
intended to be limited to the embodiments shown herein but
is to be accorded the widest scope consistent with the
following claims and the principles and novel features
disclosed herein.
All cited patents, patent applications, and other references
are incorporated herein by reference in their entirety. How-
ever, if a term in the present application contradicts or
conflicts with a term in the incorporated reference, the term
from the present application takes precedence over the
conflicting term from the incorporated reference.
All ranges disclosed herein are inclusive of the endpoints,
and the endpoints are independently combinable with each
other. Each range disclosed herein constitutes a disclosure of
any point or sub-range lying within the disclosed range.
The use of the terms "a" and "an" and "the" and similar
referents in the context of describing the invention (espe-
cially in the context of the following claims) are to be
construed to cover both the singular and the plural, unless
otherwise indicated herein or clearly contradicted by con-
text. "Or" means "and/or." As used herein, the term "and/or"
includes any and all combinations of one or more of the
associated listed items. As also used herein, the term "com-
binations thereof' includes combinations having at least one
of the associated listed items, wherein the combination can
further include additional, like non-listed items. Further, the
terms "first," "second," and the like herein do not denote any
order, quantity, or importance, but rather are used to distin-
guish one element from another. The modifier "about" used
in connection with a quantity is inclusive of the stated value
and has the meaning dictated by the context (e.g., it includes
the degree of error associated with measurement of the
particular quantity).
Reference throughout the specification to "another
embodiment", "an embodiment", "exemplary embodi-
ments", and so forth, means that a particular element (e.g.,
feature, structure, and/or characteristic) described in con-
nection with the embodiment is included in at least one
embodiment described herein, and can or cannot be present
in other embodiments. In addition, it is to be understood that
the described elements can be combined in any suitable
manner in the various embodiments and are not limited to
the specific combination in which they are discussed.
What is claimed is:
1. An assembly for identifying combined effects of micro-
gravity and radiation, the assembly comprising:
a bioreactor comprising a rotating wall vessel configured
to simulate reduced gravity in a test space therein; and
a gamma radiation source configured to provide steady
gamma radiation, wherein a specimen disposed in the
test space is exposed to the gamma radiation, the
specimen including at least one of: cells, bacteria and
viruses.
2. The assembly of claim 1, including:
a three dimensional scaffold disposed in the test space, the
three dimensional scaffold comprising a plurality of
polymer fibers configured to mimic an in vivo envi-
ronment.
3. The assembly of claim 2, wherein:
the three dimensional scaffold comprises polymer fibers.
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4. The assembly of claim 3, wherein:
the polymer fibers are disposed in a plurality of layers
having an alternating 0°/90° layup.
5. The assembly of claim 2, wherein:
5 the polymer fibers comprise electrospun polyvinylidene
fluoride.
6. The assembly of claim 1, wherein:
the gamma radiation source provides the gamma radiation
at a controlled rate.
10 7. The assembly of claim 6, wherein:
the gamma radiation source provides a low dose radiation
at a rate of about 500 µGy/day.
8. The assembly of claim 1, including:
a cell culture disposed in the rotating wall vessel.
15 9. The assembly of claim 8, wherein:
the cell culture comprises human fibroblast cells.
10. The assembly of claim 8, wherein:
the cell culture comprises human mesenchymal stem
cells.
20 11. The assembly of claim 1, including:
an incubator defining a temperature-controlled internal
space; and wherein:
the rotating wall vessel of the bioreactor is disposed inside
the internal space, and wherein the gamma radiation
25 source is disposed outside the internal space adjacent
the incubator whereby the steady gamma radiation
from the gamma radiation source is directed into the
internal space.
12. A method comprising:
30 providing a cell culture in a ground-based test environ-
ment;
exposing the cell culture to gamma radiation from a
gamma radiation source while the cell culture is simul-
taneously exposed to simulated microgravity from a
35 bioreactor comprising a rotating wall vessel configured
to simulate reduced gravity in the ground-based test
environment; and
determining a response of the cell culture to combined
environmental stressors from exposure to the gamma
40 radiation and exposure to the simulated microgravity.
13. The method of claim 12, wherein:
the cell culture comprises human mesenchymal stem
cells.
14. The method of claim 13, further comprising:
45 determining effects of combined microgravity and radia-
tion on the cell culture with respect to gene expression.
15. The method of claim 12, wherein:
the cell culture comprises a three dimensional macropo-
rous fibrous structure.
50 16. The method of claim 15, wherein:
the three dimensional macroporous fibrous structure com-
prises polymer fibers.
17. The method of claim 16, wherein:
the polymer fibers comprise electrospun polyvinylidene
55 fibers.
18. The method of claim 12, wherein:
the gamma radiation source provides low dose gamma
radiation at a rate of about 500 µGy/day.
19. The method of claim 12, wherein:
60 a response of the cell culture is utilized to develop a
treatment for diseases.
20. The method of claim 19, wherein:
the cell culture comprises at least one bacteria, and an
expression of genes in response to the combined envi-
65 ronmental stressors is utilized to develop a vaccine.
